| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.024 | 0.9 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |